Please login to the form below

Not currently logged in
Email:
Password:

US says China must improve food and drug safety

US health chief tells China to improve the safety of its food and drugs by the end of 2007

US health chief Mike Leavitt has said that China must improve the safety of its food and drugs, amid a series of international health scandals involving Chinese exports.

Leavitt stated: "Our US regulatory agencies are concerned about what they see as an insufficient infrastructure across the board in China to assure the safety, quality and effectiveness of many products exported to the US. We believe that with the technology, the scientific expertise, and the commitment each side has, we can work together to correct the outstanding issues. I am hopeful that we can achieve two strong, action-oriented documents by December."

US health officials were in Beijing, when Leavitt made his comments, as part of a series of bilateral meetings to come to an agreement over food and drug safety in the region.

China's international reputation regarding its food and drug exports has been damaged by US reports of tainted pet foods, dangerous toys, drugs and cosmetics and other products, which have led recalls and bans. Contaminated antibiotics also led to numerous death in China and other export destinations, resulting in the recent execution of the head of the Chinese equivalent of the FDA for taking bribes to approve dangerous drugs.

1st August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics